Issued Patents 2021
Showing 1–8 of 8 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11207393 | Regulatory T cell PD-1 modulation for regulating T cell effector immune responses | Arlene H. Sharpe, Loise M. Francisco, Peter T. Sage, Sun-Jong Lee, Scott B. Lovitch +2 more | 2021-12-28 |
| 11155620 | Method of detecting TIM-3 using antibody molecules to TIM-3 | Catherine Anne Sabatos-Peyton, Barbara Brannetti, Alan S. Harris, Thomas Huber, Thomas Pietzonka +9 more | 2021-10-26 |
| 11124569 | Methods of reducing liver PD-1-expressing CD8+ T cells using PD-1 Fc fusion proteins that bind Fc receptors | Rafi Ahmed, Arlene H. Sharpe, Masao Hashimoto, Hyun T. Jin | 2021-09-21 |
| 11116818 | Compositions and methods for inhibiting viral entry | Hyeryun Choe, Stephanie Jemielity, Dale T. Umetsu, Rosemarie H. De Kruyff | 2021-09-14 |
| 10981990 | Antibody molecules to TIM-3 and uses thereof | Catherine Anne Sabatos-Peyton, Barbara Brannetti, Alan S. Harris, Thomas Huber, Thomas Pietzonka +9 more | 2021-04-20 |
| 10960008 | Methods for treating PTEN deficient epithelial cancers using a combination of anti-PI3KBETA and anti-immune checkpoint agents | Jean Zhao, Johann Bergholz, Thomas M. Roberts | 2021-03-30 |
| 10948492 | PD-L2 biomarkers predictive of PD-1 pathway inhibitor responses in esophagogastric cancers | Adam Bass, Sarah Derks, Scott J. Rodig | 2021-03-16 |
| 10934353 | Single agent anti-PD-L1 and PD-L2 dual binding antibodies and methods of use | Arlene H. Sharpe | 2021-03-02 |